MiRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL

Blood

Volumn 125, Issue 19, 2015, Pages 2948-2957

  Berg, Valeska ^a,b,c   Rusch, Marion ^d   Vartak, Nachiket ^e   Jungst, Christian ^c   Schauss, Astrid ^c   Waldmann, Herbert ^d,e   Hedberg, Christian ^d   Pallasch, Christian P ^a,b,c   Bastiaens, Philippe I H ^d,e   Hallek, Michael ^a,b,c   Wendtner, Clemens Martin ^a,b,c,f   Frenzel, Lukas P ^a,b,c  

^a Department i of Internal Medicine ^*  (United States)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^e TU DORTMUND UNIVERSITY   (Germany)

^f Klinikum Schwabing   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL PROTEIN THIOESTERASE 1; ACYL PROTEIN THIOESTERASE 2; FAS ANTIGEN; MICRORNA; MICRORNA 138; MICRORNA 424; SMALL INTERFERING RNA; THIOL ESTER HYDROLASE; UNCLASSIFIED DRUG; LUCIFERASE; LYPLA1 PROTEIN, HUMAN; LYPLA2 PROTEIN, HUMAN; MESSENGER RNA; MIRN138 MICRORNA, HUMAN; MIRN424 MICRORNA, HUMAN;

APOPTOSIS; ARTICLE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; GENETICS; LIPOYLATION; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

ANTIGENS, CD95; APOPTOSIS; BLOTTING, WESTERN; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LIPOYLATION; LUCIFERASES; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THIOLESTER HYDROLASES; TUMOR CELLS, CULTURED;

EID: 84934767215     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-07-586511     Document Type: Article

References (57)

1. De Totero D, Montera M, Rosso O, et al. Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression. Hematol J. 2004;5(2):152-160.
2. Kater AP, Dicker F, Mangiola M, et al. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis. Blood. 2005;106(5):1742-1748.
3. Romano C, De Fanis U, Sellitto A, et al. Induction of CD95 upregulation does not render chronic lymphocytic leukemia B-cells susceptible to CD95-mediated apoptosis. Immunol Lett. 2005; 97(1):131-139.
4. Dicker F, Kater AP, Fukuda T, Kipps TJ. Faslig and (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells. Blood. 2005;105(8):3193-3198.
5. Krammer PH. CD95's deadly mission in the immune system. Nature. 2000;407(6805): 789-795.
6. Molica S, Mannella A, Dattilo A, et al. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis. Haematologica. 1996;81(4):302-309.
7. Grønbaek K, Straten PT, Ralfkiaer E, et al. Somatic Fas mutations in non-Hodgkin's lymphoma: Association with extranodal disease and autoimmunity. Blood. 1998;92(9):3018-3024.
8. Chakrabandhu K, Hi erincs Z, Huault S, et al. Palmitoylation is required for efficient Fas cell death signaling. EMBO J. 2007;26(1):209-220.
9. Feig C, Tchikov V, Schütze S, Peter ME. Palmitoylation of CD95 facilitates formation of SDS-stable receptor aggregates that initiate apoptosis signaling. EMBO J. 2007;26(1): 221-231.
10. Leon-Bollotte L, Subramaniam S, Cauvard O, et al. S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells. Gastroenterology. 2011;140(7):2009-2018.
11. Anathy V, Aesif SW, Guala AS, et al. Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas. J Cell Biol. 2009;184(2):241-252.
12. Magee AI, Gutierrez L, McKay IA, Marshall CJ, Hall A. Dynamic fatty acylation of p21N-ras. EMBO J. 1987;6(11):3353-3357.
13. Martin BR, Wang C, Adibekian A, Tully SE, Cravatt BF. Global profiling of dynamic protein palmitoylation. Nat Methods. 2012;9(1):84-89.
14. Yang W, Di Vizio D, Kirchner M, Steen H, Freeman MR. Proteome scale characterization of human S-acylated proteins in lipid raft-enriched and non-raft membranes. Mol Cell Proteomics. 2010;9(1):54-70.
15. Mitchell DA, Vasudevan A, Linder ME, Deschenes RJ. Protein palmitoylation by a family of DHHC protein S-acyltransferases. J Lipid Res. 2006; 47(6):1118-1127.
16. Yeh DC, Duncan JA, Yamashita S, Michel T. Depalmitoylation of endothelial nitric-oxide synthase by acyl-protein thioesterase 1 is potentiated by Ca(21)-calmodulin. J Biol Chem. 1999;274(46):33148-33154.
17. Dekker FJ, Rocks O, Vartak N, et al. Smallmolecule inhibition of APT1 affects Ras localization and signaling. Nat Chem Biol. 2010; 6(6):449-456.
18. Tian L, McClafferty H, Knaus HG, Ruth P, Shipston MJ. Distinct acyl protein transferases and thioesterases control surface expression of calcium-activated potassium channels. J Biol Chem. 2012;287(18):14718-14725.
19. Vartak N, Papke B, Grecco HE, et al. The autodepalmitoylating activity of APT maintains the spatial organization of palmitoylated membrane proteins. Biophys J. 2014;106(1):93-105.
20. Lai EC. Micro RNAs are complementary to 39 UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet. 2002; 30(4):363-364.
21. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell. 2009;136(2):215-233.
22. Pallasch CP, Patz M, Park YJ, et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood. 2009;114(15): 3255-3264.
23. Baer C, Claus R, Frenzel LP, et al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res. 2012;72(15):3775-3785.
24. Frenzel LP, Claus R, Plume N, et al. Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus. Int J Cancer. 2011;128(10):2495-2500.
25. Frenzel LP, Patz M, Pallasch CP, et al. Novel X-linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL-mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis. Br J Haematol. 2011;152(2): 191-200.
26. Schwamb J, Feldhaus V, Baumann M, et al. B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides. Blood. 2012;120(19):3978-3985.
27. Martin BR, Cravatt BF. Large-scale profiling of protein palmitoylation in mammalian cells. Nat Methods. 2009;6(2):135-138.
28. Wan J, Roth AF, Bailey AO, Davis NG. Palmitoylated proteins: Purification and identification. Nat Protoc. 2007;2(7):1573-1584.
29. Rocks O, Gerauer M, Vartak N, et al. The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins. Cell. 2010;141(3):458-471.
30. Rapsomaniki MA, Kotsantis P, Symeonidou IE, Giakoumakis NN, Taraviras S, Lygerou Z. easyFRAP: An interactive, easy-to-use tool for qualitative and quantitative analysis of FRAP data. Bioinformatics. 2012;28(13):1800-1801.
31. Pekarsky Y, Santanam U, Cimmino A, et al. Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res. 2006;66(24):11590-11593.
32. Tili E, Michaille JJ, Luo Z, et al. The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood. 2012;120(13): 2631-2638.
33. Visone R, Veronese A, Rassenti LZ, et al. miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood. 2011; 118(11):3072-3079.
34. Klein U, Lia M, Crespo M, et al. The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia. Cancer Cell. 2010;17(1):28-40.
35. Pallasch CP, Schwamb J, Königs S, et al. Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia. 2008;22(3):585-592.
36. Rusch M, Zimmermann TJ, Bürger M, et al. Identification of acyl protein thioesterases 1 and 2 as the cellular targets of the Ras-signaling modulators palmostatin B and M. Angew Chem Int Ed Engl. 2011;50(42):9838-9842.
37. Hang HC, Geutjes EJ, Grotenbreg G, Pollington AM, Bijlmakers MJ, Ploegh HL. Chemical probes for the rapid detection of Fatty-acylated proteins in Mammalian cells. J Am Chem Soc. 2007;129(10): 2744-2745.
38. Crowther-Swanepoel D, Broderick P, Di Bernardo MC, et al. Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk. Nat Genet. 2010;42(2): 132-136.
39. Di Bernardo MC, Crowther-Swanepoel D, Broderick P, et al. A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2008;40(10): 1204-1210.
40. Speedy HE, Di Bernardo MC, Sava GP, et al. A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2014;46(1):56-60.
41. Baseggio L, Geay MO, Gazzo S, et al. In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia. Br J Haematol. 2012; 158(4):489-498.
42. Ferreira PG, Jares P, Rico D, et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res. 2014;24(2):212-226.
43. Puente XS, Pinyol M, Quesada V, et al. Wholegenome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature. 2011; 475(7354):101-105.
44. Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet. 2012;44(1):47-52.
45. Charollais J, Van Der Goot FG. Palmitoylation of membrane proteins [review]. Mol Membr Biol. 2009;26(1):55-66.
46. Fr ohlich M, Dejanovic B, Kashkar H, Schwarz G, Nussberger S. S-palmitoylation represents a novel mechanism regulating the mitochondrial targeting of BAX and initiation of apoptosis. Cell Death Dis. 2014;5:e1057.
47. Tomatis VM, Trenchi A, Gomez GA, Daniotti JL. Acyl-protein thioesterase 2 catalyzes the deacylation of peripheral membrane-associated GAP-43. PLoS ONE. 2010;5(11):e15045.
48. Ahearn IM, Tsai FD, Court H, et al. FKBP12 binds to acylated H-ras and promotes depalmitoylation. Mol Cell. 2011;41(2):173-185.
49. Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme JS, Newell MK. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol. 2003;5(2):118-125.
50. Chen L, Park SM, Tumanov AV, et al. CD95 promotes tumour growth. Nature. 2010; 465(7297):492-496.
51. Meng XW, Peterson KL, Dai H, et al. High cell surface death receptor expression determines type I versus type II signaling. J Biol Chem. 2011; 286(41):35823-35833.
52. Siegel G, Obernosterer G, Fiore R, et al. A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis. Nat Cell Biol. 2009;11(6):705-716.
53. Xu J, Li Y, Wang F, et al. Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer. Oncogene. 2013;32(8):976-987.
54. Ye XW, Yu H, Jin YK, et al. miR-138 inhibits proliferation by targeting 3-phosphoinositidedependent protein kinase-1 in non-small cell lung cancer cells. Clin Respir J. 2015;9(1):27-33.
55. Garofalo M, Condorelli GL, Croce CM, Condorelli G. MicroRNAs as regulators of death receptors signaling. Cell Death Differ. 2010;17(2):200-208.
56. Hau A, Ceppi P, Peter ME. CD95 is part of a let-7/p53/miR-34 regulatory network. PLoS ONE. 2012; 7(11):e49636.
57. He J, Zhang JF, Yi C, et al. miRNA-mediated functional changes through co-regulating function related genes. PLoS ONE. 2010;5(10):e13558.